Lyudmila A. Bazhenova, MD | Authors


Outcomes of Larotretinib Confirmed in TRK Fusion-Positive Lung Cancer

January 29, 2021

Lyudmila A. Bazhenova, MD, explains the impact of having larotrectinib results in a lung cancer cohort, as seen in a presentation of data from 14 patients, given during the 2020 World Conference on Lung Cancer Singapore.